About the INTERPHEXasia Group
Have something to say?
Join LinkedIn for free to participate in the conversation. When you join, you can comment and post your own discussions.
Join LinkedIn
Most Popular Discussions
Rachel
GSK invests in Sri Lankan manufacturing plant in-pharmatechnologist.com
GSK has invested in a new manufacturing plant in Sri Lanka for the production of its over-the-counter (OTC) painkiller Panadol.
Rachel
Bristol-Myers Squibb Company and WuXi PharmaTech announced that they have entered a strategic partnership to conduct stability studies of small-molecule new chemical entities to support global marketing applications. Under the...
Rachel
ISPE Singapore Conference 2011 - INTERPHEX Asia 2011 | ISPE Singapore... interphexasia.com
“Pharmaceutical Manufacturing in Asia – Achieving Operational Excellence” With the theme of “Pharmaceutical Manufacturing in Asia – Achieving...
Rachel
Sanofi-Aventis completes acquisition of Genzyme Corporation pharmaasia.com
Sanofi-aventis announced that it has completed its acquisition of Genzyme Corporation, which is now a wholly-owned subsidiary of Sanofi-aventis. According to the company, Genzyme will become an important new platform in its...
Rachel
GlaxoSmithKline and XenoPort, Inc announced that the US Food and Drug Administration (FDA) has approved Horizant (gabapentin enacarbil) extended-release tablets for the treatment of moderate-to-severe primary Restless Legs...
Vincent
Rachel
GlaxoSmithKline Plans to Divest Select OTC Brands - Pharmaceutical... pharmtech.findpharma.com
GlaxoSmithKline (GSK) identified certain over-the-counter (OTC) brands in its consumer healthcare business that the company plans to divest.
